ProPhase Labs (PRPH)
(Real Time Quote from BATS)
$2.42 USD
+0.08 (3.42%)
Updated Sep 23, 2024 11:38 AM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Income Statements
Fiscal Year end for ProPhase Labs, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 44 | 123 | 79 | 15 | 10 |
Cost Of Goods | 28 | 52 | 37 | 10 | 7 |
Gross Profit | 16 | 71 | 42 | 5 | 3 |
Selling & Adminstrative & Depr. & Amort Expenses | 38 | 47 | 32 | 7 | 6 |
Income After Depreciation & Amortization | -22 | 24 | 10 | -2 | -3 |
Non-Operating Income | 0 | 0 | -3 | 0 | 0 |
Interest Expense | 1 | 1 | 1 | 0 | 0 |
Pretax Income | -23 | 23 | 5 | -2 | -3 |
Income Taxes | -6 | 4 | -1 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -17 | 18 | 6 | -2 | -3 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -17 | 18 | 6 | -2 | -3 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -15 | 29 | 13 | -2 | -3 |
Depreciation & Amortization (Cash Flow) | 7 | 5 | 4 | 0 | 0 |
Income After Depreciation & Amortization | -22 | 24 | 10 | -2 | -3 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 17.21 | 18.65 | 18.39 | 11.60 | 11.56 |
Diluted EPS Before Non-Recurring Items | -0.98 | 1.02 | 0.20 | -0.20 | -0.27 |
Diluted Net EPS (GAAP) | -0.98 | 1.02 | 0.40 | -0.18 | -0.27 |
Fiscal Year end for ProPhase Labs, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 2.47 | 3.63 | 3.50 | 8.37 | 13.22 |
Cost Of Goods | 2.95 | 4.07 | 6.56 | 6.04 | 6.77 |
Gross Profit | -0.48 | -0.43 | -3.06 | 2.33 | 6.45 |
SG&A, R&D, and Dept/Amort Expenses | 7.35 | 7.86 | 8.29 | 8.81 | 11.10 |
Income After SG&A, R&D, and Dept/Amort Expenses | -7.83 | -8.29 | -11.35 | -6.48 | -4.65 |
Non-Operating Income | 0.03 | -0.02 | 0.18 | -0.03 | 0.04 |
Interest Expense | 0.64 | 0.52 | 0.49 | 0.28 | 0.29 |
Pretax Income | -8.44 | -8.83 | -11.67 | -6.79 | -4.91 |
Income Taxes | -2.29 | -2.57 | -2.91 | -1.64 | -1.47 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -6.15 | -6.27 | -8.75 | -5.14 | -3.44 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -6.15 | -6.27 | -8.75 | -5.14 | -3.44 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 18.89 | 90.42 | 17.16 | 17.18 | 16.85 |
Diluted EPS Before Non-Recurring Items | -0.33 | -0.07 | -0.51 | -0.30 | -0.20 |
Diluted Net EPS (GAAP) | -0.33 | -0.35 | -0.51 | -0.30 | -0.20 |